SEN0014196

· Siena Biotech S.p.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SEN0014196, covering 2012-02-07 to 2015-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Safety and Tolerability Study With SEN0014196 [Phase 2]